A study performed in an experimental model of multiple sclerosis (MS) in mice and also analyzing cerebrospinal fluid samples taken from human patients suffering from MS showed increased LCN2 levels in the active phases of experimental autoimmune encephalomyelitis and in MS patients when compared to healthy individuals. Here, LCN2 is linked to myeloid sarcoma.